What's Going On With Kintara Therapeutics Stock?
What's Going On With Kintara Therapeutics Stock?
Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares are volatile Wednesday after the company announced it is seeking withdrawal of its registration statement for a public offering of securities.
周三，Kintara Therapeutics, Inc.（纳斯达克股票代码：KTRA）股价波动不定，此前该公司宣布正在寻求撤回其证券公开发行注册声明。
The Details:
细节：
According to documents filed with the SEC, Kintara filed the registration withdrawal request on Wednesday for a registration statement on Form S-1 initially filed on Oct. 4, 2023.
根据 文件 Kintara于周三向美国证券交易委员会提交了注册撤回申请，要求在最初于2023年10月4日提交的S-1表格上提交的注册声明。
Kintara shares are moving on heavy trading volume as inventors digest the SEC filing. According to data from Benzinga Pro, more than 100 million shares have already been traded in the session, compared to the stock's 100-day average of just over 10 million shares.
随着发明家对美国证券交易委员会的文件进行消化，Kintara的股票交易量居高不下。根据Benzinga Pro的数据，该交易日已经交易了超过1亿股股票，而该股的100天平均交易量刚刚超过1000万股。
Related News: What's Going On With 'Bitcoin Developer' MicroStrategy Stock?
相关新闻： “比特币开发者” 微策略股票怎么了？
Should I Sell My KTRA Stock?
我应该卖出我的 KTRA 股票吗？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在决定持有或出售股票时，投资者应考虑其时间范围、未实现收益和总回报。
Shares of Kintara Therapeutics have decreased by 97.05% in the past year. An investor who bought shares of Kintara Therapeutics at the beginning of the year would take a loss of $0.06 per share if they sold it today. The stock has fallen 14.99% over the past month, meaning an investor who bought shares on Feb. 1 would see a capital loss of $0.03.
在过去的一年中，Kintara Therapeutics的股价下跌了97.05％。年初购买Kintara Therapeutics股票的投资者如果今天出售Kintara Therapeutics的股票，则每股亏损0.06美元。该股在过去一个月中下跌了14.99％，这意味着在2月1日购买股票的投资者将遭受0.03美元的资本损失。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Kintara Therapeutics stock currently has an RSI of 23.07, indicating oversold conditions.
投资者也可以考虑市场动态。相对强弱指数可用于表明股票是超买还是超卖。Kintara Therapeutics股票目前的相对强弱指数为23.07，这表明存在超卖情况。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要访问高级制图和分析工具以及股票数据，请查看 Benzinga PRO。免费试用。
KTRA Price Action: According to Benzinga Pro, Kintara Therapeutics shares are up 13% at 9 cents at the time of publication.
KTRA价格走势：根据Benzinga Pro的数据，Kintara Therapeutics的股价在发布时上涨了13％，至9美分。
Image: Akava Photo from Pixabay
图片：Akava 照片 来自 Pixabay